Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 25;7(7):CD011161.
doi: 10.1002/14651858.CD011161.pub2.

Sun protection for preventing basal cell and squamous cell skin cancers

Guillermo Sánchez  1 , John Nova, Andrea Esperanza Rodriguez-Hernandez, Roger David Medina, Carolina Solorzano-Restrepo, Jenny Gonzalez, Miguel Olmos, Kathie Godfrey, Ingrid Arevalo-Rodriguez
Affiliations

Sun protection for preventing basal cell and squamous cell skin cancers

Guillermo Sánchez et al. Cochrane Database Syst Rev. .

Abstract

Background: 'Keratinocyte cancer' is now the preferred term for the most commonly identified skin cancers basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), which were previously commonly categorised as non-melanoma skin cancers (NMSC). Keratinocyte cancer (KC) represents about 95% of malignant skin tumours. Lifestyle changes have led to increased exposure to the sun, which has, in turn, led to a significant increase of new cases of KC, with a worldwide annual incidence of between 3% and 8%. The successful use of preventive measures could mean a significant reduction in the resources used by health systems, compared with the high cost of the treatment of these conditions. At present, there is no information about the quality of the evidence for the use of these sun protection strategies with an assessment of their benefits and risks.

Objectives: To assess the effects of sun protection strategies (i.e. sunscreen and barrier methods) for preventing keratinocyte cancer (that is, basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) of the skin) in the general population.

Search methods: We searched the following databases up to May 2016: the Cochrane Skin Group Specialised Register, CENTRAL, MEDLINE, Embase, and LILACS. We also searched five trial registries and the bibliographies of included studies for further references to relevant trials.

Selection criteria: We included randomised controlled clinical trials (RCTs) of preventive strategies for keratinocyte cancer, such as physical barriers and sunscreens, in the general population (children and adults), which may provide information about benefits and adverse events related to the use of solar protection measures. We did not include trials focused on educational strategies to prevent KC or preventive strategies in high-risk groups. Our prespecified primary outcomes were BCC or cSCC confirmed clinically or by histopathology at any follow-up and adverse events.

Data collection and analysis: Two review authors independently selected studies for eligibility using Early Review Organizing Software (EROS). Similarly, two review authors independently used predesigned data collection forms to extract information from the original study reports about the participants, methods of randomisation, blinding, comparisons of interest, number of participants originally randomised by arm, follow-up losses, and outcomes, and they assessed the risk of bias. We resolved any disagreement by consulting a third author and contacted trial investigators of identified trials to obtain additional information. We used standard methodological procedures expected by Cochrane.

Main results: We included one RCT (factorial design) that randomised 1621 participants.This study compared the daily application of sunscreen compared with discretionary use of sunscreen, with or without beta-carotene administration, in the general population. The study was undertaken in Australia; 55.2% of participants had fair skin, and they were monitored for 4.5 years for new cases of BCC or cSCC assessed by histopathology. We found this study to be at low risk of bias for domains such as allocation, blinding, and incomplete outcome data. However, we found multiple unclear risks related to other biases, including an unclear assessment of possible interactions between the effects of the different interventions evaluated (that is, sunscreen and beta-carotene). We found no difference in terms of the number of participants developing BCC (n = 1621; risk ratio (RR) 1.03, 95% confidence interval (CI) 0.74 to 1.43) or cSCC (n = 1621; RR 0.88, 95% CI 0.50 to 1.54) when comparing daily application of sunscreen with discretionary use, even when analyses were restricted to groups without beta-carotene supplementation. This evidence was of low quality, which means that there is some certainty that future studies may alter our confidence in this evidence.We reported adverse events in a narrative way and included skin irritation or contact allergy.We identified no studies that evaluated other sun protection measures, such as the use of sun-protective clothing, sunglasses, or hats, or seeking the shade when outdoors.

Authors' conclusions: In this review, we assessed the effect of solar protection in preventing the occurrence of new cases of keratinocyte cancer. We only found one study that was suitable for inclusion. This was a study of sunscreens, so we were unable to assess any other forms of sun protection. The study addressed our prespecified primary outcomes, but not most of our secondary outcomes. We were unable to demonstrate from the available evidence whether sunscreen was effective for the prevention of basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC).Our certainty in the evidence was low because there was a lack of histopathological confirmation of BCC or cSCC in a significant percentage of cases. Amongst other sources of bias, it was not clear whether the study authors had assessed any interaction effects between the sunscreen and beta-carotene interventions. We think that further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.

PubMed Disclaimer

Conflict of interest statement

Guillermo Sánchez: nothing to declare. John Nova: nothing to declare. Andrea Esperanza Rodriguez‐Hernandez: nothing to declare. Roger David Medina: nothing to declare. Carolina Solorzano‐Restrepo: nothing to declare. Jenny Gonzalez: nothing to declare. Miguel Olmos: nothing to declare. Kathie Godfrey: nothing to declare. Ingrid Arevalo‐Rodriguez: nothing to declare.

Figures

1
1
Study flow diagram
2
2
'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study
1.1
1.1. Analysis
Comparison 1 Daily application of sunscreen versus discretionary use (including beta‐carotene use), Outcome 1 BCC confirmed clinically or histopathologically at any follow‐up.
1.2
1.2. Analysis
Comparison 1 Daily application of sunscreen versus discretionary use (including beta‐carotene use), Outcome 2 cSCC confirmed clinically or histopathologically at any follow‐up.
1.3
1.3. Analysis
Comparison 1 Daily application of sunscreen versus discretionary use (including beta‐carotene use), Outcome 3 Actinic or solar keratoses at any follow‐up.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD011161

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Green 1999 {published data only}
    1. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Archives of Dermatology 2003;139(4):451‐5. [PUBMED: 12707092] - PubMed
    1. Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, et al. The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants. Controlled Clinical Trials 1994;15(6):512‐22. [PUBMED: 7851112] - PubMed
    1. Green A, Williams G, Neale R. Daily use of beta carotene supplements did not prevent skin cancer, but daily sunscreen use reduced the incidence of squamous cell carcinomas: Commentary. Evidence‐Based Medicine 2000;5(3):91. [DOI: 10.1136/ebm.5.3.91] - DOI
    1. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal‐cell and squamous‐cell carcinomas of the skin: a randomised controlled trial. Lancet 1999;354(9180):723‐9. [PUBMED: 10475183] - PubMed
    1. Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicine 2013;158(11):781‐90. [PUBMED: 23732711] - PubMed

References to studies excluded from this review

Autier 1999 {published data only}
    1. Autier P, Dore J, Negrier S, Lienard D, Panizzon R, Lejeune FJ, et al. Sunscreen use and duration of sun exposure: a double‐blind, randomized trial. Journal of the National Cancer Institute 1999;91(15):1304‐9. [PUBMED: 10433619] - PubMed
Bauer 2005 {published data only}
    1. Bauer J, Buttner P, Wiecker TS, Luther H, Garbe C. Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. International Journal of Cancer 2005;116(5):755‐61. [PUBMED: 15849749] - PubMed
Bauer 2014 {published data only}
    1. Bauer A, Hault K, Puschel A, Ronsch H, Knuschke P, Beissert S. Acceptance and usability of different sunscreen formulations among outdoor workers: a randomized, single‐blind, cross‐over study. Acta Dermato‐Venereologica 2014;94(2):152‐6. [PUBMED: 23995520] - PubMed
Buller 2011 {published data only}
    1. Buller DB, Reynolds KD, Ashley JL, Buller MK, Kane IL, Stabell CL, et al. Motivating public school districts to adopt sun protection policies: a randomized controlled trial. American Journal of Preventive Medicine 2011;41(3):309‐16. [PUBMED: 21855746] - PMC - PubMed
Carrera 2013 {published data only}
    1. Carrera C, Puig‐Butille JA, Aguilera P, Ogbah Z, Palou J, Lecha M, et al. Impact of sunscreens on preventing UVR‐induced effects in nevi: in vivo study comparing protection using a physical barrier vs sunscreen. JAMA Dermatology 2013;149(7):803‐13. [PUBMED: 23699984] - PubMed
Dobbinson 2009 {published data only}
    1. Dobbinson SJ, White V, Wakefield MA, Jamsen KM, Livingston PM, English DR, et al. Adolescents' use of purpose built shade in secondary schools: cluster randomised controlled trial. BMJ 2009;338:b95. [PUBMED: 19223344] - PMC - PubMed
Duffy 2013 {published data only}
    1. Duffy SA, Ronis DL, Waltje AH, Choi SH. Protocol of a randomized controlled trial of sun protection interventions for operating engineers. BMC Public Health 2013;13:273. [PUBMED: 23530608] - PMC - PubMed
Dupuy 2005 {published data only}
    1. Dupuy A, Dunant A, Grob JJ, Reseau d'Epidemiologie en Dermatologie. Randomized controlled trial testing the impact of high‐protection sunscreens on sun‐exposure behavior. Archives of Dermatology 2005;141(8):950‐6. [PUBMED: 16103322] - PubMed
Giles‐Corti 2004 {published data only}
    1. Giles‐Corti B, English DR, Costa C, Milne E, Cross D, Johnston R. Creating SunSmart schools. Health Education Research 2004;19(1):98‐109. [PUBMED: 15020549] - PubMed
Glanz 2010 {published data only}
    1. Glanz K, Schoenfeld ER, Steffen A. A randomized trial of tailored skin cancer prevention messages for adults: Project SCAPE. American Journal of Public Health 2010;100(4):735‐41. [PUBMED: 20167900] - PMC - PubMed
Gordon 2009 {published data only}
    1. Gordon LG, Scuffham PA, Pols JC, McBride P, Williams GM, Green AC. Regular sunscreen use is a cost‐effective approach to skin cancer prevention in subtropical settings. Journal of Investigative Dermatology 2009;129(12):2766‐71. [PUBMED: 19536149] - PubMed
Hirst 2012 {published data only}
    1. Hirst NG, Gordon LG, Scuffham PA, Green AC. Lifetime cost‐effectiveness of skin cancer prevention through promotion of daily sunscreen use. Value in Health 2012;15(2):261‐8. [PUBMED: 22433757] - PubMed
Janda 2014 {published data only}
    1. Janda M, Stoneham M, Youl P, Crane P, Sendall MC, Tenkate T, et al. What encourages sun protection among outdoor workers from four industries?. Journal of Occupational Health 2014;56(1):62‐72. [PUBMED: 24270927] - PubMed
Lagerlund 2006 {published data only}
    1. Lagerlund M, Dixon HG, Simpson JA, Spittal M, Taylor HR, Dobbinson SJ. Observed use of sunglasses in public outdoor settings around Melbourne, Australia: 1993 to 2002. Preventive Medicine 2006;42(4):291‐6. [PUBMED: 16487999] - PubMed
Manion 1997 {published data only}
    1. Manion IG, Cloutier PF, Klassen TP. Ultraviolet radiation and safety behaviours at an outdoor community event. Canadian Journal of Public Health. Revue Canadienne de Sante Publique 1997;88(2):119‐22. [PUBMED: 9170691] - PMC - PubMed
Marks 1995 {published data only}
    1. Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Archives of Dermatology 1995;131(4):415‐21. [PUBMED: 7726582] - PubMed
Mayer 2007 {published data only}
    1. Mayer JA, Slymen DJ, Clapp EJ, Pichon LC, Eckhardt L, Eichenfield LF, et al. Promoting sun safety among US Postal Service letter carriers: impact of a 2‐year intervention. American Journal of Public Health 2007;97(3):559‐65. [PUBMED: 17267715] - PMC - PubMed
Schalka 2009 {published data only}
    1. Schalka S, dos Reis VM, Cuce LC. The influence of the amount of sunscreen applied and its sun protection factor (SPF): evaluation of two sunscreens including the same ingredients at different concentrations. Photodermatology, Photoimmunology & Photomedicine 2009;25(4):175‐80. [PUBMED: 19614894] - PubMed
Thompson 1993 {published data only}
    1. Cockburn J, Thompson SC, Marks R, Jolley D, Schofield P, Hill D. Behavioural dynamics of a clinical trial of sunscreens for reducing solar keratoses in Victoria, Australia. Journal of Epidemiology & Community Health. 1997;51(6):716‐21. [PUBMED: 9519139] - PMC - PubMed
    1. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. New England Journal of Medicine 1993;329(16):1147‐51. [PUBMED: 8377777] - PubMed
Vuong 2014 {published data only}
    1. Vuong K, Trevena L, Bonevski B, Armstrong BK. Feasibility of a GP delivered skin cancer prevention intervention in Australia. BMC Family Practice 2014;15:137. [PUBMED: 25070692] - PMC - PubMed
Wolf 2003 {published data only}
    1. Wolf P, Hoffmann C, Quehenberger F, Grinschgl S, Kerl H. Immune protection factors of chemical sunscreens measured in the local contact hypersensitivity model in humans. Journal of Investigative Dermatology 2003;121(5):1080‐7. [PUBMED: 14708610] - PubMed

Additional references

Albert 2003
    1. Albert MR, Weinstock MA. Keratinocyte carcinoma. CA: a Cancer Journal for Clinicians 2003;53(5):292‐302. [PUBMED: 14570228] - PubMed
Bath‐Hextall 2007
    1. Bath‐Hextall Fiona J, Leonardi‐Bee J, Somchand N, Webster Angela C, Dellit J, Perkins W. Interventions for preventing non‐melanoma skin cancers in high‐risk groups. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD005414.pub2; CD005414] - DOI - PMC - PubMed
Begg 1994
    1. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088‐101. [MEDLINE: ] - PubMed
Bimczok 2007
    1. Bimczok R, Gers‐Barlag H, Mundt C, Klette E, Bielfeldt S, Rudolph T, et al. Influence of applied quantity of sunscreen products on the sun protection factor‐‐a multicenter study organized by the DGK Task Force Sun Protection. Skin Pharmacology & Physiology 2007;20(1):57‐64. [PUBMED: 17035723 ] - PubMed
Brok 2009
    1. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta‐analyses may be inconclusive‐‐Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology 2009;38(1):287‐98. [MEDLINE: ] - PubMed
Burnett 2012
    1. Burnett ME, Hu JY, Wang SQ. Sunscreens: obtaining adequate photoprotection. Dermatologic Therapy 2012;25(3):244‐51. [PUBMED: 22913442] - PubMed
Ciapponi 2011
    1. Ciapponi A, Glujovsky D, Bardach A, García Martí S, Comande D. EROS: a new software for early stage of systematic reviews. HTAi 2011 Conference. Rio de Janeiro, Brazil, 2011. [DOI: 10.1016/j.jval.2011.08.1689] - DOI
Cole 2001
    1. Cole C. Sunscreen protection in the ultraviolet A region: how to measure the effectiveness. Photodermatology, Photoimmunology & Photomedicine 2001;17(1):2‐10. [PUBMED: 11169170] - PubMed
Cooley 2013
    1. Cooley JH, Quale LM. Skin cancer preventive behavior and sun protection recommendations. Seminars in Oncology Nursing 2013;29(3):223‐6. [PUBMED: 23958220] - PubMed
Corona 2001
    1. Corona R, Dogliotti E, D'Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Archives of Dermatology 2001;137(9):1162‐8. [PUBMED: 11559211] - PubMed
CTU 2011 [Computer program]
    1. Central Trial Unit. TSA ‐ Trial Sequential Analysis. Version 0.9 Beta. Copenhagen: Central Trial Unit, 2011. [http://ctu.dk/tsa/]
Darlington 2003
    1. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Archives of Dermatology 2003;139(4):451‐5. [PUBMED: 12707092] - PubMed
Diaz 2013
    1. Diaz JH, Nesbitt LT. Sun exposure behavior and protection: recommendations for travelers. Journal of Travel Medicine 2013;20(2):108‐18. [PUBMED: 23464719] - PubMed
Dubas 2013
    1. Dubas LE, Ingraffea A. Nonmelanoma skin cancer. Facial Plastic Surgery Clinics of North America 2013;21(1):43‐53. [PUBMED: 23369588] - PubMed
Egger 1997
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34. [MEDLINE: ] - PMC - PubMed
Gasparro 1998
    1. Gasparro FP, Mitchnick M, Nash JF. A review of sunscreen safety and efficacy. Photochemistry & Photobiology 1998;68(3):243‐56. [PUBMED: 9747581] - PubMed
Glass 1989
    1. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262(15):2097‐100. [PUBMED: 2795783] - PubMed
Gloster 1996
    1. Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatologic Surgery 1996;22(3):217‐26. [PUBMED: 8599733] - PubMed
Glujovsky 2010
    1. Glujovsky D, Bardach A, García Martí S, Comande D, Ciapponi A. New Software for Early Stage of Systematic Reviews. XVIII Cochrane Colloquium. The Joint Colloquium of the Cochrane & Campbell Collaborations. Keystone Resort, Colorado, USA, 2010.
Glujovsky 2011
    1. Glujovsky D, Bardach A, García Martí S, Comande D, Ciapponi A. EROS: a new software for early stage of systematic reviews (Poster PRM2). Value in Health. ISPOR 3rd Latin America Conference, Mexico City, Mexico, 8‐10 September 2011 2011;14(7):A564.
Green 1994
    1. Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, et al. The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants. Controlled Clinical Trials 1994;15(6):512‐22. [PUBMED: 7851112] - PubMed
Green 2010
    1. Green AC, McBride P. Squamous cell carcinoma of the skin (non‐metastatic). Clinical Evidence (Online) 2010;2010:1709. [PUBMED: 21733203] - PMC - PubMed
Guyatt 2008
    1. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995‐8. [PUBMED: 18456631] - PMC - PubMed
Guyatt 2011
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence‐‐inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294‐302. [PUBMED: 21803546] - PubMed
Guyatt 2011a
    1. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence‐‐publication bias. Journal of Clinical Epidemiology 2011;64(12):1277‐82. [PUBMED: 21802904] - PubMed
Guyatt 2011b
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence‐‐indirectness. Journal of Clinical Epidemiology 2011;64(12):1303‐10. [PUBMED: 21802903] - PubMed
Guyatt 2011c
    1. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso‐Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence‐‐study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407‐15. [PUBMED: 21247734] - PubMed
Guyatt 2011d
    1. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso‐Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311‐6. [PUBMED: 21802902] - PubMed
Guyatt 2011e
    1. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence‐‐imprecision. Journal of Clinical Epidemiology 2011;64(12):1283‐93. [PUBMED: 21839614] - PubMed
Guyatt 2011f
    1. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [PUBMED: 21195583] - PubMed
Guyatt 2011g
    1. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395‐400. [PUBMED: 21194891] - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. [PUBMED: 12958120] - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011.
Holman 1984
    1. Holman CD, Evans PR, Lumsden GJ, Armstrong BK. The determinants of actinic skin damage: problems of confounding among environmental and constitutional variables. American Journal of Epidemiology 1984;120(3):414‐22. [PUBMED: 6475917] - PubMed
Jansen 2013a
    1. Jansen R, Osterwalder U, Wang SQ, Burnett M, Lim HW. Photoprotection: part II. Sunscreen: development, efficacy, and controversies. Journal of the American Academy of Dermatology 2013;69(6):867. [PUBMED: 24238180] - PubMed
Jansen 2013b
    1. Jansen R, Wang SQ, Burnett M, Osterwalder U, Lim HW. Photoprotection: part I. Photoprotection by naturally occurring, physical, and systemic agents. Journal of the American Academy of Dermatology 2013;69(6):853. [PUBMED: 24238179] - PubMed
Johnson 1992
    1. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). Journal of the American Academy of Dermatology 1992;26(3 Pt 2):467‐84. [PUBMED: 1564155] - PubMed
Klostermann 2013
    1. Klostermann S, Bolte G. Determinants of inadequate parental sun protection behaviour in their children ‐ Results of a cross‐sectional study in Germany. International Journal of Hygiene & Environmental Health 2013 Aug 1 [Epub ahead of print]. [PUBMED: 23988730] - PubMed
Kopcke 2008
    1. Kopcke W, Krutmann J. Protection from sunburn with beta‐Carotene‐‐a meta‐analysis. Photochemistry and photobiology 2008;84(2):284‐8. [PUBMED: 18086246] - PubMed
Kornek 2013
    1. Kornek T, Augustin M. Skin cancer prevention. Journal of the German Society of Dermatology 2013;11(4):283‐96; quiz 297‐8. [PUBMED: 23574893] - PubMed
Langbecker 2014
    1. Langbecker D, Diaz A, Chan Raymond J, Marquart L, Hevey D, Hamilton J. Educational programmes for primary prevention of skin cancer. Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD011061] - DOI
Lansbury 2010
    1. Lansbury L, Leonardi‐Bee J, Perkins W, Goodacre T, Tweed JA, Bath‐Hextall FJ. Interventions for non‐metastatic squamous cell carcinoma of the skin. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD007869.pub2; PUBMED: 20393962] - DOI - PMC - PubMed
Latha 2013
    1. Latha MS, Martis J, Shobha V, Sham Shinde R, Bangera S, Krishnankutty B, et al. Sunscreening agents: a review. Journal of Clinical & Aesthetic Dermatology 2013;6(1):16‐26. [PUBMED: 23320122] - PMC - PubMed
Lear 1997
    1. Lear JT, Tan BB, Smith AG, Bowers W, Jones PW, Heagerty AH, et al. Risk factors for basal cell carcinoma in the UK: case‐control study in 806 patients. Journal of the Royal Society of Medicine 1997;90(7):371‐4. [PUBMED: 9290417] - PMC - PubMed
Linos 2011
    1. Linos E, Keiser E, Fu T, Colditz G, Chen S, Tang JY. Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness. Cancer Causes & Control 2011;22(7):1067‐71. [PUBMED: 21637987] - PMC - PubMed
Lomas 2012
    1. Lomas A, Leonardi‐Bee J, Bath‐Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. British Journal of Dermatology 2012;166(5):1069‐80. [PUBMED: 22251204] - PubMed
Lucas 2006
    1. Lucas R, McMichael T, Smith W, Armstrong B. Solar ultraviolet radiation: Global burden of disease from solar ultraviolet radiation. World Health Organization, Environmental Burden of Disease Series, No. 13 2006.
Maslin 2014
    1. Maslin DL. Do suncreens protect us?. International Journal of Dermatology 2014;53(11):1319‐23. [PUBMED: 25208462] - PubMed
McQuay 1998
    1. McQuay HJ, Moore RA. An Evidence‐Based Resource for Pain Relief. Oxford: Oxford University Press, 1998.
Miller 2010
    1. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, et al. Basal cell and squamous cell skin cancers. Journal of the National Comprehensive Cancer Network 2010;8(8):836‐64. [PUBMED: 20870631] - PubMed
Morales‐Sánchez 2016
    1. Morales‐Sánchez MA, Peralta‐Pedrero ML, Jurado‐Santa Cruz F, Pomerantz H, Allen V, Barajas‐Nava LA. Interventions for preventing keratinocyte cancer in high‐risk groups not receiving immunosuppressive therapy. Cochrane Database of Systematic Reviews 2016, Issue 6. [DOI: 10.1002/14651858.CD012266] - DOI
Motley 2003
    1. Motley R, Kersey P, Lawrence C, British Association of Dermatologists, British Association of Plastic Surgeons. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Journal of Plastic Surgery 2003;56(2):85‐91. [PUBMED: 12791348] - PubMed
Mulliken 2012
    1. Mulliken JS, Russak JE, Rigel DS. The effect of sunscreen on melanoma risk. Dermatologic Clinics 2012;30(3):369‐76. [PUBMED: 22800545] - PubMed
Neale 2002
    1. Neale RE, Green AC. Measuring behavioral interventions by questionnaires and prospective diaries: an example of sunscreen use. Epidemiology 2002;13(2):224‐7. [PUBMED: 11880765] - PubMed
NICE 2011
    1. National Institute for Health and Clinical Excellence. Skin cancer prevention: information, resources and environmental changes. NICE guidelines [PH 32], January 2011. www.nice.org.uk/guidance/ph32. Manchester, UK, (accessed 23 September 2015).
Pissavini 2013
    1. Pissavini M, Diffey B. The likelihood of sunburn in sunscreen users is disproportionate to the SPF. Photodermatology, Photoimmunology & Photomedicine 2013;29(3):111‐5. [PUBMED: 23651270] - PubMed
Pogue 1997
    1. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta‐analysis. Controlled Clinical Trials 1997;18(6):580‐93; discussion 661‐6. [MEDLINE: ] - PubMed
Pogue 1998
    1. Pogue J, Yusuf S. Overcoming the limitations of current meta‐analysis of randomised controlled trials. Lancet 1998;351(9095):47‐52. [MEDLINE: ] - PubMed
Preston 1992
    1. Preston DS, Stern RS. Nonmelanoma cancers of the skin. New England Journal of Medicine 1992;327(23):1649‐62. [PUBMED: 1435901] - PubMed
Ravanat 2001
    1. Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. Journal of Photochemistry & Photobiology. B ‐ Biology 2001;63(1‐3):88‐102. [PUBMED: 11684456] - PubMed
Review Manager 2012 [Computer program]
    1. The Nordic Cochrane Centre. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, 2012.
Ricotti 2009
    1. Ricotti C, Bouzari N, Agadi A, Cockerell CJ. Malignant skin neoplasms. Medical Clinics of North America 2009;93(6):1241‐64. [PUBMED: 19932329] - PubMed
Roewert‐Huber 2007
    1. Roewert‐Huber J, Lange‐Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. British Journal of Dermatology 2007;157(Suppl 2):47‐51. [EMBASE: 2007579513] - PubMed
Rubin 2005
    1. Rubin AI, Chen EH, Ratner D. Basal‐cell carcinoma. New England Journal of Medicine 2005;353(21):2262‐9. [DOI: 10.1056/NEJMra044151] - DOI - PubMed
Saki 2012
    1. Saki M, Toulany M, Sihver W, Zenker M, Heldt JM, Mosch B, et al. Cellular and molecular properties of (90)Y‐labeled cetuximab in combination with radiotherapy on human tumor cells in vitro. Strahlentherapie und Onkologie 2012;188(9):823‐32. [PUBMED: 22875052] - PubMed
Sambandan 2011
    1. Sambandan DR, Ratner D. Sunscreens: an overview and update. Journal of the American Academy of Dermatology 2011;64(4):748‐58. [PUBMED: 21292345] - PubMed
Schalka 2011
    1. Schalka S, Reis VM. Sun protection factor: meaning and controversies. Anais Brasileiros de Dermatologia 2011;86(3):507‐15. [PUBMED: 21738968] - PubMed
Stern 2010
    1. Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence‐based model. Archives of Dermatology 2010;146(3):279‐82. [PUBMED: 20231498] - PubMed
Sterne 2011
    1. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ 2011;343:d4002. [MEDLINE: ] - PubMed
Sánchez 2011
    1. Sánchez G, Nova J, Hoz F, Castañeda C. Incidence of skin cancer in Colombia from 2003‐2007 [Incidencia de cáncer de piel en Colombia, años 2003‐2007]. Piel 2011;26(4):171‐7. [DOI: 10.1016/j.piel.2010.10.028] - DOI
Sánchez 2012
    1. Sánchez G, Nova J, Hoz F. Risk factors for basal cell carcinoma: a study from the national dermatology center of Colombia [Factores de riesgo de carcinoma basocelular. Un estudio del Centro Nacional de Dermatologia de Colombia]. Actas Dermo‐Sifiliográficas 2012;103(4):294‐300. [PUBMED: 22078143] - PubMed
Sánchez 2013
    1. Sánchez G, Nova J. Risk factors for squamous cell carcinoma, a study by the national dermatology centre of Colombia. Actas Dermo‐Sifiliográficas 2013;104(8):672‐8. [PUBMED: 23968667] - PubMed
Sánchez 2014
    1. Sánchez G, Nova J, Rodriguez‐Hernandez AE, Solorzano‐Restrepo C, Gonzalez J, Olmos M, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD011161] - DOI - PMC - PubMed
Telfer 2008
    1. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. British Journal of Dermatology 2008;159(1):35‐48. [PUBMED: 18593385] - PubMed
Thorlund 2009
    1. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?. International Journal of Epidemiology 2009;38(1):276‐86. [MEDLINE: ] - PubMed
Thorlund 2011
    1. Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta‐analysis‐‐a simulation study. PLoS One [Electronic Resource] 2011;6(10):e25491. [MEDLINE: ] - PMC - PubMed
van der Pols 2006
    1. Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiology, Biomarkers & Prevention 2006;15(12):2546‐8. [PUBMED: 17132769] - PubMed
Wetterslev 2008
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology 2008;61(1):64‐75. [MEDLINE: ] - PubMed
Zanetti 1996
    1. Zanetti R, Rosso S, Martinez C, Navarro C, Schraub S, Sancho‐Garnier H, et al. The multicentre south European study 'Helios' I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. British Journal of Cancer 1996;73(11):1440‐6. [EMBASE: 1996180527] - PMC - PubMed
Zelen 1988
    1. Zelen M. Are primary cancer prevention trials feasible?. Journal of the National Cancer Institute 1988;80(18):1442‐4. [PUBMED: 3054126] - PubMed

Publication types

MeSH terms

LinkOut - more resources